Insider Trading & Ownership of Jason P. Rhodes

Location
Cambridge, MA
Summary
The estimated net worth of Jason P. Rhodes is at least $22,294,937 dollars as of 30 Apr 2026. Jason P. Rhodes is the Director of Dyne Therapeutics, Inc. and owns shares of Dyne Therapeutics, Inc. (DYN) stock worth about $22.02M. Jason P. Rhodes is the Director of Generation Bio Co. and owns shares of Generation Bio Co. stock worth about $275.4K.
Signature
/s/ Ommer Chohan, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Jason P. Rhodes and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Sign up to save research and follow filings

Quick Takeaways

  • Jason P. Rhodes has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $22,294,937.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Dyne Therapeutics, Inc. ($22,019,537).
  • Past-year value change for that position: -$27,757,023.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Jason P. Rhodes

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
DYN Dyne Therapeutics, Inc. Director $22,019,537 -$27,757,023 -56% 28 Apr 2026
GBIO Generation Bio Co. Director $275,400 09 Feb 2026
IRON Gemini Therapeutics, Inc. /DE Director, 10%+ Owner 04 Oct 2021
REPL Replimune Group, Inc. Director 01 Apr 2022

Insider Transactions Reported by Jason P. Rhodes:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .